ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,889Medicare Part D Prescriptions Filled, Including Refills

Rank: 338 out of 1383

$451K Total Retail Price of All Prescriptions

Rank: 424 out of 1383

454 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 7,403 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 423 341 1 4
PRAVASTATIN SODIUM 344 242 2 14
METFORMIN HCL 342 263 3 8
OMEPRAZOLE 305 215 4 5
RANITIDINE HCL 286 190 5 19
METOPROLOL TARTRATE 263 218 6 9
LISINOPRIL 255 217 7 3
FUROSEMIDE 222 194 8 7
SIMVASTATIN 211 170 9 2
AMLODIPINE BESYLATE 177 158 10 6
HYDROCODONE-ACETAMINOPHEN 170 117 S3 11 1
BENAZEPRIL HCL 165 125 12 38
ENALAPRIL MALEATE 156 135 13 75
HYDROCHLOROTHIAZIDE 153 129 14 10
ATENOLOL 143 125 15 16
WARFARIN SODIUM 138 117 16 13
LOVASTATIN 136 102 17 22
ALLOPURINOL 119 93 18 33
SERTRALINE HCL 118 91 19 21
TAMSULOSIN HCL 111 109 20 30
NEXIUM 110 50 21 26
CARVEDILOL 107 75 22 24
ZOLPIDEM TARTRATE 107 54 22 17
POTASSIUM CHLORIDE 105 80 24 12
LOSARTAN POTASSIUM 101 84 25 23
PROAIR HFA 98 62 26 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 48 27 27
VERAPAMIL ER 93 90 28 84
GLYBURIDE 92 62 R 29 46
MELOXICAM 90 47 30 20
CLOPIDOGREL 87 69 31 28
ATORVASTATIN CALCIUM 79 59 32 18
SPIRIVA 79 66 32 45
HYDRALAZINE HCL 76 67 34 86
POLYETHYLENE GLYCOL 3350 75 67 35 64
CITALOPRAM HBR 73 37 36 15
GABAPENTIN 71 57 37 11
AZITHROMYCIN 68 43 38 41
AMITRIPTYLINE HCL 68 54 R 38 57
PAROXETINE HCL 67 55 40 55
GEMFIBROZIL 61 52 41 90
CEPHALEXIN 61 47 41 87
GLIMEPIRIDE 60 27 43 31
LANTUS 58 40 44 50
DOXYCYCLINE HYCLATE 58 41 44 94
TRAZODONE HCL 58 28 44 36
TRAMADOL HCL 57 42 47 25
PLAVIX 56 42 48 43
CIPROFLOXACIN HCL 55 37 49 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 33 49 89
METOPROLOL SUCCINATE 54 54 51 29
DIOVAN 53 43 52 58
DONEPEZIL HCL 53 53 52 35
TRIAMTERENE-HCTZ 52 40 54 48
FENOFIBRATE 51 39 55 65
DILTIAZEM 24HR CD 50 41 56 95
BUMETANIDE 50 41 56 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.